The US's third coronavirus surge may become the deadliest yet, experts say
coronaviruscases in the US have risen nearly 40%, on average, since the start of October.
- Experts worry these cases will lead to the nation's deadliest surge of infections yet, as more people gather indoors for the holidays and become more lax about masks and social distancing.
- The US is also approaching peak flu season, which can lead to overcrowding at hospitals.
The 1918 flu pandemic sparked three waves of infections, the deadliest of which occurred in the fall. The US is now on track to see a similar trend, experts say. The nation's new daily cases have risen nearly 40%, on average, since October 1.Experts predict this third surge could be the deadliest yet due to a perfect storm of factors.
View all Offers
Dettol Original Germ Protection Bathing Soap bar, 125 gm, Buy 4 Get 1 Free₹ 220Buy On
Dettol Original Germ Protection Liquid Handwash Refill, 1500ml (Price Off)₹ 208Buy On
Mamaearth Onion Hair Fall Shampoo for Hair Growth & Hair Fall Control, with Onion Oil & Plant Keratin 250ml₹ 349Buy On
- 30% OFF
Pampers All round Protection Pants, Large size baby diapers (LG) 64 Count, Anti Rash diapers, Lotion with Aloe Vera₹ 801₹ 1149Buy On
- 6% OFF
Parachute jumbo pack 100% pure coconut oil 600 ml (bottle )₹ 236₹ 250Buy On
"My worry is that we're just going to be completely overwhelmed," Megan Ranney, an emergency-medicine physician at Brown University, told Business Insider. "Even if we do better on a case-by-case basis, I think that the number of deaths that we're going to experience this fall and winter is going to dwarf what we've already been through."It might be a different story if the US had managed to lower its baseline of cases to less than 10,000 per day, experts say, since that would make subsequent spikes less dramatic. But the lowest cases ever got after the spring surge was around 20,000 per day.
The nation is now seeing nearly 60,000 daily cases, on average.The University of Washington's Institute for Health Metrics and Evaluation predicts that nearly 170,000 more people in the US could die from now through February 1.
The third surge is more rural and widespreadDuring the second surge over the summer, the US got better at diagnosing milder cases as testing became more widely available. Younger people also made up a much larger share of cases compared to the spring. Combined, these factors made the second peak less deadly than the first.
But experts worry about the prospect of increased cases among older residents this fall.
"With the advent of the holidays, and the increased indoor time, it means that we are going to be getting potentially older people sicker — people that had managed to avoid infection up until now," Ranney said.The latest surge is also more widespread than its predecessors. All but five states have seen cases rise in the last two weeks, with Midwestern states particularly hard-hit.
"Our entire healthcare system is going to be stretched at the same time," Ranney said. "The second thing that concerns me is that it is more rural, so it's occurring in hospitals that have less capacity to begin with."
Indeed, the states with the highest current numbers of new cases per capita — North Dakota, South Dakota, and Montana — have particularly large rural populations: more than 40% of the states' totals.
Flu season creates an unprecedented challengeWidespread adoption of masks and social distancing could reduce the number of flu cases this fall. This has already happened in Australia, which recorded just 21,000 flu cases as of August 23, compared to more than 247,000 by that same time the year before.
Since COVID-19 shares many of same symptoms as seasonal influenza, Ranney said, doctors will be inclined to treat any report of flu-like symptoms with extreme caution."It's going to be really tough for us as physicians to tell one from the other in the early stages," she said. "God forbid that people get co-infected with both. We don't even know what that's going to look like."
Treatments may prevent some deaths, but not all
Physicians have gotten better at treating COVID-19 since the start of the pandemic. In critical cases, doctors usually prescribe the steroid
A soon-to-be-published study in the Journal of Hospital Medicine found that mortality among hospitalized patients in one New York City health system dropped by 18 percentage points from March to August. At the start of the pandemic, patients in the study had a 26% chance of dying, the researchers found. But by the end of the study, patients only had an 8% chance of dying.
Still, scientists remain skeptical of the benefits of the treatments the FDA has authorized so far. Some say it's too early to know whether convalescent plasma is really a useful therapy, while others have questioned whether remdesivir reduces mortality."On the chance that it may help people, we're using it, because there aren't better options right now," Ranney said.
Meanwhile, doctors are still struggling to keep patients alive, and many hospitals continue to run low on tests and personal protective equipment, along with certain drugs.
"We have no magic bullets," Ranney said. "Despite Trump's claims, there are no cures right now. In fact, I'm hearing reports from colleagues in some locations across the country that are running out of remdesivir and convalescent plasma. We have dexamethasone abundantly right now, but we've experienced shortages of that in the past."Ranney said doctors should brace for a 30% increase in hospitalizations next week and a 30% increase in deaths two or three weeks from now.
- Weekend watch list for OTT — Fahadh Faasil’s Malik to Farhan Akhtar’s Toofan and more
- Reliance Retail surprises all by more than doubling its net profit in the last three months
- Reliance Jio adds 42 million subscribers but the average revenue is pretty much the same
- YES Bank’s net profit grows four fold as provision for bad loans shrink
- Amazon Prime Day 2021: Best deals and offers on headphones